Is the Options Market Predicting a Spike in BioCryst Pharmaceuticals Stock?

view original post

Investors in BioCryst Pharmaceuticals, Inc. BCRX need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 20, 2026 $2.00 Call had some of the …